Search    ENTER KEYWORD
MSDS Material Safety Data Sheet
CAS

64742-89-8
108-88-3
67-64-1
67-63-0

File Name: 64742-89-8.asp

                                       MATERIAL SAFETY DATA SHEET
BIX餂? PAINT DEGLOSSER
COMPANY NAME AND ADDRESS: NFPA Rating: H=3, F=3, R=0

Of飥乧e: Plant: (24 HOUR) EMERGENCY PHONE:
BIX MFG. CO. BIX MFG. CO. INFOTRAC (800) 535-5053
PO Box 69 2011 Ashland City Hwy. Effective: May 10, 2002
Ashland City, TN 37015 Ashland City, TN 37015 Supersedes: April 1, 1997
PHONE: (615) 792-3260 / (800) 251-1098
Internet: www.bixmfg.com

INGREDIENTS:
Regulatory Information
DOT Shipping Classi飥乧ation: Quarts 鈥? Consumer Commodity ORM-D; Gallons or larger 鈥? Paint Related Material, 3, UN1263, PGII
All ingredients used in BIX餂? PAINT DEGLOSSER are TSCA listed.
The following ingredients are regulated under Section 313 of Title III of SARA of 1986 and 40 CFR 372.65: Toluene, Aliphatic Petroleum Distillate
The following ingredients are regulated as a hazardous substance per 40 CFR 302: Acetone, Toluene, Aliphatic Petroleum Distillate, and Isopropanol
The California Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65) prohibits contaminating any known source of drinking water with
substances known to cause cancer and/or reproductive toxicity.

Material or Component CAS Number OSHA PEL ACGIH TLV Approx. %
Aliphatic Petroleum Distillates 64742-89-8 400 ppm None Established 30 - 60 %
Toluene 108-88-3 200 ppm 50 ppm 15 - 20 %
Acetone 67-64-1 1000 ppm 750 ppm 25 - 35 %
Isopropanol 67-63-0 400 ppm 400 ppm 10 - 30 %

PHYSICAL DATA:
Boiling Point (for COMPONENT) 56.11掳C Speci飥乧 Gravity @ 77掳F .775
Vapor Pressure Formulation (for COMPONENT) 181.7 mm Hg at 20掳C Percent Volatiles 100%
Vapor Density Heavier than Air Appearance Clear to light amber
Odor Aromatic ether like odor Evaporation Rate Slower than Ether

FIRE AND EXPLOSION HAZARD DATA:
Flash Point (TCC) < 20掳F Flammable Limits in Air (Lowest Value of Component) 1.2%
Extinguisher Media Water fog, dry chemical, carbon dioxide, and/or foam.
Special Fire Fighting Procedures Fire 飥乬hter should have eye and full face protection and wear self contained breathing apparatus in the
positive pressure demand mode.
Unusual Fire and Explosion Hazards Vapors are heavier than air and may travel to a source of ignition and 飥俛sh back. Never use welding or
cutting
torch on or near container (even empty) because product (even just residue) can ignite explosively.
Material is highly volatile and readily gives off vapors which may travel along the ground or be
moved by ventilation and ignited by pilot lights, other 飥俛mes, sparks, heaters, smoking, electric
motors, static discharge, or other ignition sources at locations distant from material handling point.

PHYSICAL HAZARDS / REACTIVITY DATA:
Stability Stable Conditions to Avoid High temperatures
Incompatibility Strong acids and/or oxidizers Hazardous Polymerization Will not occur
Hazardous Decomposition Combustion produces unidenti飥乪d organics, oxides of carbon, carbon dioxide, carbon monoxide, ammonia, nitrogen oxides,
and toxic and hazardous phosgene gas.
Other Do not add nitrites due to possible formation of nitrosoamines (potential carcinogen).

SPECIAL PRECAUTIONS FOR SAFE HANDLING AND USE:
Handling and Storage Store in cool ventilated area away from ignition sources. Keep containers tightly closed.
Other Precautions Avoid acids and oxidizers. No smoking or eating in handling areas.
Material Release or Spill Shut off ignition sources. Stop leak if you can do it without risk. Use water spray to reduce vapors. For small liquid
spills, take up with sand, earth, or other absorbent material. For larger spills, dike far ahead of spill for later disposal. No
smoking, 飥俛mes, or 飥俛res in hazard area! Keep unnecessary people and those not wearing protective equipment away.
Avoid contamination of water sources.
Disposal of Material Consult your local federal, state, county, or city regulations on proper methods of disposal.
HEALTH HAZARD DATA:
Route of Entry Inhalation: Yes Skin: Yes Ingestion: Yes
Acute Health Effects
EYES - Causes irritation, redness, tearing.
SKIN - Prolonged or repeated contact can cause moderate irritation, defatting, dermatitis.
BREATHING - Excessive inhalation of vapors can cause nasal and respiratory irritation, central nervous system effects including dizziness, weakness,
fatigue, nausea, headache and possible unconsciousness, and even death.
INGESTION - Can cause gastrointestinal irritation, nausea, vomiting, and diarrhea.

Toluene:
INHALATION: Irritant / Narcotic / Neurotoxin. 500 ppm Immediately Dangerous to Life or Health. Odor detection may be insuf飥乧ient for warning due to
olfactory fatigue. Exposure to 100 ppm may cause irritation. 200-600 ppm for up to 8 hours caused fatigue, weakness, confusion, headache, nausea,
impaired coordination and reaction time, paresthesias of the skin, euphoria, dizziness, and dilated pupils. 800 ppm caused rapid irritation, nasal mucous
secretion, metallic taste, drowsiness, and impaired balance. After effects including nervousness, muscular fatigue, and insomnia lasted for several days.
Death may be due to respiratory failure or ventricular 飥乥rillation.
SKIN CONTACT: Irritant. Contact with this liquid may cause irritation. Skin absorption does occur, but it is generally too slow to produce signs
of acute systemic toxicity.
EYE CONTACT: Irritant. Liquid may cause irritation and corneal burns if not promptly removed. Concentrations around 300-800 ppm may cause
noticeable irritation and lacrimation. Corneal lesions and very 飥乶e vacuoles have been reported in workers exposed to a solvent containing toluene.
The lesions subsided following several days of non-exposure.
INGESTION: Narcotic. May cause a burning sensation in the epigastrium and abdominal spasms. Systemic effects may occur as described in acute
inhalation. Aspiration of the liquid into the lungs may cause coughing, gagging, distress, acute hemorrhagic pneumonitis, and rapidly developing edema.
The approximate lethal dose in humans is 15-30 ml.
Acetone:
INHALATION: Irritant / Narcotic. 2500 ppm Immediately Dangerous to Life or Health. Vapor concentrations around 1000 ppm may cause slight transient
irritation of the upper respiratory tract. Exposure to 12000 ppm has caused throat irritation and central nervous system depression with weakness
of the legs, headache, dizziness, drowsiness, nausea, and a general feeling of malaise. Other possible effects from exposure to high concentrations
include dryness of the mouth and throat, incoordination of motion and speech, restlessness, anorexia, abdominal pain, vomiting, sometimes followed by
hematemesis, hypothermia, dyspnea, slow, irregular respiration, slow, weak pulse, progressive collapse with stupor, and in severe cases, coma. Blood
glucose levels may be affected and fatal ketosis is possible.
SKIN CONTACT: Irritant. Cellular damage to the outer layers of the epitheluim with mild edema and hyperemia has been demonstrated in humans, but
was readily reversible. Small amounts may be absorbed through intact skin.
EYE CONTACT: Irritant. In humans, vapors produce only slight irritation when the concentration is at or below 1000 ppm. However, high vapor
concentrations have caused corneal epithelial and conjunctival injury in animals. Liquid splashed in human eyes causes and immediate stinging
sensation and, if washed promptly, damage only to the corneal epithelium characterized by microscopic gray dots and a foreign body sensation, which
heals completely in 1-2 days.
INGESTION: Narcotic. May cause a fruity odor of the breath and mucous membrane and gastroenteric irritation. In acute cases, a latent period may
be followed by restlessness, diarrhea, nausea, and vomiting proceeding to hematemesis and progressive collapse with stupor. Hepatorenal lesions have
been reported. The blood glucose level may be affected and ketosis may be fatal. 10-20 milliliters have been tolerated without ill effects. Large amounts
have produced lethargy, pharyngeal, and soft palate erosions, and erythema. 200 milliliters have caused stupor within a half hour, 飥倁shed cheeks,
shallow respiration, and coma which lasted for 12 hours. Renal glucosuria persisted for 5 months.

Chronic Health Effects

Overexposure to this material (or its components) has apparently been found to cause the following effects in laboratory animals: Liver abnormalities,
kidney damage, eye damage, lung damage, spleen damage, brain damage.

Overexposure to this material (or its components) has been suggested as a cause of the following effects in humans: Liver abnormalities, kidney
damage.

Toluene:
INHALATION: Prolonged or repeated exposure may cause mucous membrane irritation, vomiting, insomnia, nosebleeds, chest pains, euphoria,
headache, vertigo, nausea, anorexia, momentary loss of memory, loss of coordination and impairment of reaction time, tinnitus, impaired speech,
vision, and/or hearing, alcohol intolerance, and petechiae and abnormal bleeding. Bone marrow hypoplasia and leukopenia have been reported
occasionally, but may be due to benzene contamination. Examination of workers exposed to 100-1100 ppm revealed hepatomegaly, mild macrocytosis,
moderate erythropenia, and absolute lymphocytosis but no leukopenia. Other workers exposed to toluene fumes developed leukopenia and especially
neutropenia. Within 6 months, they showed decreased prothrombin level and increased coagulation time. Periodontal effects were also noted.
Volunteers exposed to 200 ppm for 6 hours/day for 2 days showed a signi飥乧ant increase in heart rate. Cardiac sensitization may occur and may result
in cardiac arrest due to ventricular 飥乥rillation. Repeated inhalation to the point of euphoria has caused irreversible encephalopathy with cerebellar
ataxia, rhythmic limb movements, disequilibrium, bizarre behavior, emotional ability, optic atrophy, and diffuse cerebral atrophy. Other neuropsychiatric
effects may include dizziness, syncope, paresthesias, peripheral neuropathy, hallucinations, lethargy, and coma. Intentional snif飥乶g can produce renal
tubular defects with metabolic acidosis, electrolyte abnormalities, and potassium loss. Severe muscle weakness leading to limb paralysis and cardiac
arrhythmias may result from the hypokalemia; however, sensory function and tendon re飥俥xes are not impaired. Gastrointestinal effects may include
abdominal pain, nausea, vomiting, and hematemesis. Chromosome changes were observed in some workers up to two years after cessation of
exposure to toluene. Women occupationally exposed to toluene and other varnish solvents have reported menstrual disorders, underweight offspring
who did not nurse well, and fetal asphyxia. One case study indicated toluene apparently crossed the placenta and created cerebellar damage in
an unborn infant. Dysmenorrhea has been reported in women occupationally exposed to toluene levels of 60-100 ppm. Reproductive effects have
also been reported in animals.
SKIN CONTACT: Prolonged or repeated contact with the liquid may cause defatting of the skin with a dry 飥乻sured dermatitis. Repeated application
to rabbit skin produced slight to moderate irritation and slight necrosis. Topical application of 10 g/kg produced and increase in plasmic and lymphoid
reticular cells in bone marrow of rats, while 1 g/kg had no effect.
HEALTH HAZARD DATA (cont.):
EYE CONTACT: Repeated or prolonged contact with irritants may cause conjunctivitis.
INGESTION: No effects were reported in rats fed up to 590 mg/kg/day for 193 days. Administration to animals during gestation produced signi飥乧ant
embryolethality and an increase in cleft palate in offspring.

Acetone:
INHALATION: Workers exposed to 500 ppm / 6 hours / 6 days experienced mucous membrane irritation, an unpleasant smell, heavy eyes, overnight
headache, and general weakness accompanied by hematologic changes. Recovery occurred in several days. Workers exposed to 1000 ppm for 3
hours / day for 7-15 years reported chronic in飥俛mmation of the respiratory tract, stomach, and duodenum, dizziness, loss of strength, and asthenia.
Drowsiness, vertigo, sensation of heat, and coughing have also been reported from chronic exposure to low concentrations. Reproductive effects
have been reported in animals.
SKIN CONTACT: Repeated or prolonged exposure may cause dermatitis with drying, cracking, and erythema due to the defatting action accompanied
by persistent paresthesia of the 飥乶gers. The amount absorbed through the skin increases directly with the frequency and extent of the exposure. Two or
three guinea pigs exposed by skin contact for 3 weeks developed cataracts by the end of three months.
EYE CONTACT: Prolonged or repeated exposure to the vapors may cause irritation or conjunctivitis.
INGESTION: Rats administered 25000 ppm in their drinking water for 14 days showed depressed growth, 飥倁id intake, and feed consumption. Rats
given 100,000 ppm showed mild debilitation, depressed weight gain, emaciated appearance, and bone marrow hyperplasia. Male rats in 13 week
studies developed depressed sperm motility and caudal and epididymal weights, an increased incidence of abnormal sperm and nephrophathy. Rats
developed anemia and splenic pigmentation (hemosiderosis) at levels of 20000 and 50000 ppm. In both the 14 day and 13 week studies, mice
developed centrilobular hepatocellular hypertrophy.
Chemical Ingredients Listed as a Carcinogen or Potential Carcinogen
National Toxicology Program: None
IARC Monographs: None
OSHA Regulated: None

Signs and Symptoms of Exposure
Irritating to eyes, possibly severe. May cause eye damage. Skin irritation may occur. Additional effects may include tingling sensation. Vapor
exposure may cause irritation, possibly severe. Additional effects may include nausea, blood in the urine, irregular heartbeat, headache, drunkenness,
numbness, suffocation, lung congestion, blood disorders, lack of sense of smell, metallic taste, headache, drowsiness, tingling sensation, dilated pupils,
liver and kidney damage, nerve damage, ringing in the ears, digestive disorders, twitching, visual disturbances, low body temperature, yellowing of the
skin and eyes, stomach pain, bloody vomit, dif飥乧ulty breathing, and coma. Ingestion may cause blood in the urine, drunkenness, tingling sensation,
suffocation, blood disorders, convulsions, lung congestion, nausea, vomiting, possibly with blood, diarrhea, dif飥乧ulty breathing, low blood pressure,
irregular heartbeat, headache, drowsiness, disorientation, hearing loss, intolerance of the eyes to light, blindness, bluish skin color, nerve damage,
convulsions, redness of the skin, and coma.

Emergency and First Aid Procedures for Overexposure
Inhalation Remove person to fresh air. If necessary, restore and support breathing. If breathing is dif飥乧ult, give oxygen. Get immediate medical
attention.
Eyes Immediately 飥倁sh with water for 15 minutes while lifting eyelids and rolling eyes. Get immediate medical attention.
Skin Wash promptly with soap and water. May dry out skin. Get medical attention if irritation occurs. Remove contaminated clothing. Launder
clothing before reuse.
Ingestion Get immediate medical attention. If conscious and medical help is not readily available, give 1 to 2 glasses of water and keep at rest. Never
attempt to give anything by mouth to an unconscious person. Induce vomiting only at the advice of a physician. Aspiration of material into
the lungs due to vomiting can cause chemical pneumonitis which can be fatal.


SPECIAL PROTECTION AND CONTROL MEASURES:
Respiratory Protection Under normal ventilated use conditions, personal respiratory protection is typically not required. If misting or vapors occur,
use NIOSH approved organic vapor air purifying respirator.
Ventilation Provide general or local exhaust ventilation for areas of use.
Protective Gloves Use chemical resistant gloves.
Eye Protection Chemical goggles, safety glasses or face shield should be worn when handling this material. Contact lenses should not
be worn when handling this material.
Other Protective Equipment Eye fountain and/or safety shower should be readily available. Long sleeves, aprons or other personal clothing protection
is suggested to avoid skin exposure.
Work Hygiene Practices Avoid contact with this material. Do not eat, drink or smoke when handling this material.

Note: Personal protection information given is based upon the general information as to normal uses and conditions. Where special or unusual uses
or conditions exist, it is suggested that the expert assistance of an industrial hygienist or other quali飥乪d professional be sought.

The data contained herein is based on information currently available to BIX Mfg. Co., Incorporated and is believed to be factual. As a formulator, blender, and compounder,
BIX Mfg. Co., Incorporated does not manufacture the raw materials used in this product and correspondingly relies on information provided to BIX Mfg. Co., Incorporated
from material safety data sheets on the speci飥乧 raw materials in the construction of this material safety data sheet. Such information is to the best of BIX Mfg. Co.,
Incorporated鈥檚 knowledge and belief to be accurate and reliable as of the date of this MSDS. HOWEVER, NO REPRESENTATION, WARRANTY OR GUARANTEE IS MADE
AS TO THE ACCURACY, RELIABILITY, OR COMPLETENESS. It is the user鈥檚 responsibility to satisfy himself as to the suitability and completeness of such information
for his own particular application. This information is not intended to be all-inclusive as to the manner and conditions of use, handling and storage. Other factors
may involve other or additional safety or performance considerations. This data is not to be taken as a warranty or representation of which BIX Mfg. Co., Incorporated
assumes legal responsibility.

ALL Chemical Analysis PAGES IN THIS GROUP
NAMECAS
biosearchtech_com_101024.asp N/A
biosolutionsllc_com_C&G_Window&Glass.asp N/A
15630-89-4.asp 15630-89-4
15630-89-4.asp 15630-89-4 68439-57-6
biotium_com_msds31000.asp N/A
biotrin_com_MSDS__Nephkit_Alpha_GST_EIA__BIO66NEPHA.asp N/A
biotrin_com_MSDS__OxyDNA_Test__BIO81DNA.asp N/A
biotrin_com_MSDS__Pi_GST_EIA__BIO85.asp N/A
biotrin_com_MSDS__Rat_Urinary_RPA1_EIA__BIO89_RPA1.asp N/A
7664-93-9.asp 7664-93-9 54-64-8 68-12-2 54827-17-7 1405-41-0
bioversal_com_MSDSQFDE.asp N/A
7732-18-5.asp 7732-18-5 67-56-1
68391-01-5.asp 68391-01-5
bissettnursery_com_msdsenvironmelt.asp N/A
64742-89-8.asp 64742-89-8 108-88-3 67-64-1 67-63-0
3171-69-9.asp 3171-69-9 1309-37-1 20344-49-4 1317-61-9
10034-76-1.asp 10034-76-1 10101-41-4
14808-60-7.asp 14808-60-7 65997-15-1 1317-65-3 68131-74-8 65997-69-2
108-05-4.asp 108-05-4 9003-20-7 7732-18-5
7646-85-7.asp 7646-85-7 7647-01-0 12125-02-9
7440-31-5.asp 7440-31-5 7439-92-1 7440-50-8 7440-36-0 7440-69-9 7440-22-4 7440-66-6 8050-09-7
7439-92-1.asp 7439-92-1
2005-07-1.asp 2005-07-1 7440-31-5 7439-92-1 8050-09-7
108-88-3.asp 108-88-3
7778-18-9.asp 7778-18-9
6363-53-7.asp 6363-53-7 69-79-4
120-20-0.asp 120-20-0 01-02-0 6420-82-4 86508-42-1
68457-79-4.asp 68457-79-4 27136-73-8
bodineelectric_com_lo_38.asp N/A
bodyconcept_ch_msdssgregulardfe.asp N/A
bomac_net_au_Paratak_Plus_40.asp N/A
2426-08-6.asp 2426-08-6 9046-10-0 14808-60-7
7440-22-4.asp 7440-22-4 114-40-0 2426-08-6 25068-38-6
78-93-3.asp 78-93-3 109-99-9 25068-38-6 5026-74-4 872-50-4 108-88-3
bondprousa_thomasnet_com_2164BPAKMSDS.asp N/A
bondprousa_thomasnet_com_2221BPAKMSDS.asp N/A
bondprousa_thomasnet_com_4104BPAKMSDS.asp N/A
bondprousa_thomasnet_com_7102BPAKMSDS.asp N/A
27546-07-2.asp 27546-07-2
52645-53-1.asp 52645-53-1
bonideproducts_com_allseasonc.asp N/A
17927-65-0.asp 17927-65-0
8003-34-7.asp 8003-34-7 51-03-6
523158-07-8.asp 523158-07-8
52918-63-5.asp 52918-63-5
16672-87-0.asp 16672-87-0
bonideproducts_com_funglconc.asp N/A
17375-41-6.asp 17375-41-6 1317-65-3
1344-81-6.asp 1344-81-6
121-75-5.asp 121-75-5


HBCChem,Inc

Chemical Information Net chemcas.orgCopyright Reserved

Trading Lead

Leputech HPLC Laboratory